Global Information
회사소개 | 문의 | 비교리스트

세계의 감염증 검사 시장 : 예측과 기회(-2025년)

Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938724
페이지 정보 영문 112 Pages
가격
US $ 4,450 ₩ 5,088,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,231,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,805,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 감염증 검사 시장 : 예측과 기회(-2025년) Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 112 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 감염증 검사 시장은 예측기간 동안 높은 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다. 세계 감염증 검사 시장은 전세계적으로 감염증을 가지고 있는 인구 증가에 의해 성장이 견인되고 있습니다. 또한 전세계 정부의 의료 인프라에 대한 투자는 예측기간 동안 시장 성장을 뒷받침할 것으로 예상됩니다. 의료 분야의 연구개발 활동 증가에 의해 향후 몇 년간 시장 성장이 더욱 가속화될 것으로 예상됩니다.

세계의 감염증 검사(Infectious Disease Testing) 시장을 부문/지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 세계의 감염증 검사 시장에 대한 코로나19(COVID-19)의 영향

제4장 개요

제5장 고객의 견해

제6장 세계의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별(분석 키트 및 시약, 기기, 서비스 및 소프트웨어)
    • 기술별(면역진단, 임상미생물학, 중합효소연쇄반응(PCR), 등온 핵산증폭기술(INAAT)의 DNA 시퀀싱 및 차세대 시퀀싱(NGS), DNA 마이크로어레이 등)
    • 질환별(간염, HIV, HAIS, HPV, TB, 인플루엔자, 선열, 코로나바이러스, 기타)
    • 최종사용자별(병원/임상검사실, 표준실험실, Physician Office, 학술기관/연구기관 등)
    • 기업별
    • 지역별
  • 시장 매력 지수

제7장 아시아태평양의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 질환별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 아시아태평양 : 국가 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국
    • 인도네시아
    • 싱가포르
    • 말레이시아

제8장 유럽의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 질환별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 유럽 : 국가 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 터키

제9장 북미의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 질환별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 북미 : 국가 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 질환별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 남미 : 국가 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 감염증 검사 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 제품 및 서비스별
    • 기술별
    • 질환별
    • 최종사용자별
    • 국가별
    • 경쟁 전망
  • 중동 및 아프리카 : 국가 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이집트
    • 나이지리아

제12장 시장 역학

  • 성장 촉진요인
  • 과제

제13장 시장 동향과 발전

제14장 특허 분석

제15장 경쟁 상황

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Luminex
  • Meridian Bioscience
  • Quidel
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific
  • Johnson and Johnson
  • F. Hoffmann-La Roche Ltd
  • Cepheid

제16장 전략적 권장사항

제17장 면책조항

LSH 20.06.19

Global infectious disease testing market is expected to grow at a significant CAGR during the forecast period. The global infectious disease testing market is driven by rising populace having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of market over the next few years.

The global infectious disease testing market is segmented based on product and service, technology, disease, end user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.

Major players operating in the global infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global infectious disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global infectious disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global infectious disease testing market based on product and service, technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global infectious disease testing market.
  • To identify drivers and challenges for global infectious disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infectious disease testing market.
  • To conduct pricing analysis for global infectious disease testing market.
  • To identify and analyze the profile of leading players operating in global infectious disease testing market.
  • To identify key sustainable strategies adopted by market players in global infectious disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global infectious disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global infectious disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Infectious Disease Testing Market, By Product and Service:

Assays, Kits, & Reagents

Instruments

Services & Software

  • Global Infectious Disease Testing Market, By Technology:

Immunodiagnostics

Clinical Microbiology

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-Generation Sequencing

DNA Microarray

Other Technologies

  • Global Infectious Disease Testing Market, By Disease:

Hepatitis

HIV

HAIS

HPV

TB

Influenza

Glandular fever

Coronavirus

Others

  • Global Infectious Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Academic/Research Institutes

Other

  • Global Infectious Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Netherland
  • Russia
  • Turkey

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Malaysia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infectious disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Infectious Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Infectious Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
    • 6.2.2. By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)
    • 6.2.3. By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular fever, Coronavirus, Others)
    • 6.2.4. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Infectious Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Technology
    • 7.2.3. By Disease
    • 7.2.4. By End User
    • 7.2.5. By Country
    • 7.2.6. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Infectious Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Infectious Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Infectious Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Infectious Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Infectious Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User
    • 7.3.6. Indonesia Infectious Disease Testing Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product and Service
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By Disease
        • 7.3.6.2.4. By End User
    • 7.3.7. Singapore Infectious Disease Testing Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Product and Service
        • 7.3.7.2.2. By Technology
        • 7.3.7.2.3. By Disease
        • 7.3.7.2.4. By End User
    • 7.3.8. Malaysia Infectious Disease Testing Market Outlook
      • 7.3.8.1. Market Size & Forecast
        • 7.3.8.1.1. By Value
      • 7.3.8.2. Market Share & Forecast
        • 7.3.8.2.1. By Product and Service
        • 7.3.8.2.2. By Technology
        • 7.3.8.2.3. By Disease
        • 7.3.8.2.4. By End User

8. Europe Infectious Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Technology
    • 8.2.3. By Disease
    • 8.2.4. By End User
    • 8.2.5. By Country
    • 8.2.6. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Infectious Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Infectious Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Infectious Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Infectious Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Infectious Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User
    • 8.3.6. Netherland Infectious Disease Testing Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product and Service
        • 8.3.6.2.2. By Technology
        • 8.3.6.2.3. By Disease
        • 8.3.6.2.4. By End User
    • 8.3.7. Russia Infectious Disease Testing Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Product and Service
        • 8.3.7.2.2. By Technology
        • 8.3.7.2.3. By Disease
        • 8.3.7.2.4. By End User
    • 8.3.8. Turkey Infectious Disease Testing Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Product and Service
        • 8.3.8.2.2. By Technology
        • 8.3.8.2.3. By Disease
        • 8.3.8.2.4. By End User

9. North America Infectious Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Technology
    • 9.2.3. By Disease
    • 9.2.4. By End User
    • 9.2.5. By Country
    • 9.2.6. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Infectious Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Infectious Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Infectious Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Infectious Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Technology
    • 10.2.3. By Disease
    • 10.2.4. By End User
    • 10.2.5. By Country
    • 10.2.6. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Infectious Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Infectious Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Infectious Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Infectious Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Technology
    • 11.2.3. By Disease
    • 11.2.4. By End User
    • 11.2.5. By Country
    • 11.2.6. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Infectious Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Infectious Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Infectious Disease Testing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product and Service
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Disease
        • 11.3.4.2.4. By End User
    • 11.3.5. Nigeria Infectious Disease Testing Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product and Service
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Disease
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories
  • 15.2. Becton, Dickinson and Company
  • 15.3. Biomerieux SA
  • 15.4. Bio-Rad Laboratories
  • 15.5. Danaher Corporation
  • 15.6. Diasorin
  • 15.7. Luminex
  • 15.8. Meridian Bioscience
  • 15.9. Quidel
  • 15.10. Roche Diagnostics
  • 15.11. Siemens AG
  • 15.12. Thermo Fisher Scientific
  • 15.13. Johnson and Johnson
  • 15.14. F. Hoffmann-La Roche Ltd
  • 15.15. Cepheid

16. Strategic Recommendations

17. About Us & Disclaimer

Back to Top
전화 문의
F A Q